Mugridge K G, Perretti M, Becherucci C, Parente L
Sclavo Research Centre, Laboratory of Pharmacology, Siena, Italy.
J Pharmacol Exp Ther. 1991 Jan;256(1):29-37.
Human recombinant interleukin-1 beta (hrIL-1 beta) potentiated CaCl2-induced contractions of isolated stomach strip preparations from adrenalectomized rats (ADXSS). Associated with this effect were increased prostaglandin E2 and peptidyl leukotriene (LT) synthesis. Unlike preparations from normal rat stomach strips or sham-operated animals, tissue responses and eicosanoid production of ADXSS failed to return to pre-hrIL-1 beta control levels after washout of the interleukin, these effects being abrogated by the lipoxygenase inhibitor nordihydroguaiaretic acid. Additionally, the LTD4 antagonist FPL55712 also prevented the increase in contraction and prostaglandin E2 synthesis caused by hrIL-1 beta without decreasing peptidyl LT synthesis. In separate experiments, hrIL-1 beta failed to increase the recovery of arachidonic acid-induced contractions after aspirin pretreatment in both ADXSS and rat stomach strips. The data indicate that the effects caused by hrIL-1 beta on ADXSS are possibly the result of an exacerbated phospholipase A2 activity particularly inasmuch as increases in cellular cyclooxygenase synthesis are unlikely in this experimental system. It appears likely that a peptidyl LT is involved in this process. Elevation of phospholipase A2 activity by interleukin-1 like drugs may be an important factor limiting the use of these agents as adjuvants particularly in patients with low blood glucocorticoid levels.
人重组白细胞介素-1β(hrIL-1β)增强了肾上腺切除大鼠离体胃条制备物(ADXSS)中氯化钙诱导的收缩。与此效应相关的是前列腺素E2和肽基白三烯(LT)合成增加。与正常大鼠胃条或假手术动物的制备物不同,在冲洗白细胞介素后,ADXSS的组织反应和类花生酸生成未能恢复到hrIL-1β处理前的对照水平,这些效应被脂氧合酶抑制剂去甲二氢愈创木酸消除。此外,LTD4拮抗剂FPL55712也能防止hrIL-1β引起的收缩增加和前列腺素E2合成增加,而不会降低肽基LT合成。在单独的实验中,hrIL-1β未能增加阿司匹林预处理后ADXSS和大鼠胃条中花生四烯酸诱导的收缩恢复。数据表明,hrIL-1β对ADXSS的影响可能是磷脂酶A2活性增强的结果,特别是因为在该实验系统中细胞环氧化酶合成增加的可能性不大。似乎肽基LT参与了这一过程。白细胞介素-1样药物引起的磷脂酶A2活性升高可能是限制这些药物作为佐剂使用的一个重要因素,尤其是在血液糖皮质激素水平较低的患者中。